Transcranial magnetic stimulation and Parkinson's disease

Roberto Cantello1, Roberto Tarletti, Carlo Civardi

  • 1Department of Medical Sciences, Section of Neurology, School of Medicine, 'Amedeo Avogadro' University, Novara, Italy. cantello@med.unipmn.it

Summary

Transcraneal magnetic stimulation (TMS) reveals significant corticospinal pathway alterations in Parkinson's disease (PD), including altered excitability and defective voluntary output activation. Levodopa treatment partially restores these functions, highlighting the primary motor cortex's role in PD.

Related Concept Videos